Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy Subjects
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- Gannex Pharma Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT04679129
- Locations
- 🇺🇸
ICON early Phase Services LLC, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath